InvestorsHub Logo
Followers 2
Posts 104
Boards Moderated 0
Alias Born 12/05/2011

Re: None

Sunday, 04/22/2018 9:55:53 AM

Sunday, April 22, 2018 9:55:53 AM

Post# of 108191
Smoking gun proof that B/O is on the way would be if Amgen did indeed take down the last share offering. So far nobody knows who took down the latest offering and nobody here has even attempted to explain this huge missing piece of the puzzle. But for arguments sake let's assume they did purchase the 10m offering, that would give them 13m out our 52m outstanding, a full 25% ownership stake. If so from their point of view any negotiated purchase price is really just a negotiation for 75% of the shares as they would already own the remaining balance of 25% under this scenario. So for simplicity sake call it a $4B price tag only nets them $3B out of pocket and subtract out the $500m that they would owe themselves for the future licensing that they have agreed to --- we are talking roughly $2.5B net out of pocket. $2.5B to assume ownership of our science from A-Z and just as important, unfettered freedom to bring any/all of our technology to market in a more efficient manner than our management team has shown. If so it's really not that far fetched that we are in play for B/O! Here's hoping the "best bio stock company to work for in New Jersey" becomes the best bio stock investment in New Jersey.....
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ADXS News